Related Experiment Video
Updated: Aug 11, 2026
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized
Heleen J van Beekhuizen1, Akosua N J A de Groot, Theo De Boo
1Jeroen Bosch Hospital, s-Hertogenbosch, The Netherlands.
Objective:
The purpose of this study was to determine the extent that the administration of sulprostone reduces the need for manual removal of the placenta in patients with retained placenta.
Study Design:
A double-blinded sequential randomized controlled trial of sulprostone versus placebo was conducted among 103 patients with retained placenta.
Results:
In the first phase of this sequential study, sulprostone was compared with placebo. The null hypothesis of equal effectiveness of both treatments was rejected after 50 patients. In patients with retained placenta, the placenta was expelled after sulprostone in 13 of 24 cases (51.8%, bias adjusted), whereas expulsion after placebo was achieved in only 4 of 26 cases (17.6%, bias adjusted). The difference was significant (P = .034). In the second phase of the study, in which the placebo arm was stopped, results were confirmed; in 25 of 53 patients (47%), the placenta was expelled.
Conclusion:
Sulprostone reduces the need for the manual removal of the placenta by 49%.